PubRank

Dae Ro Choi

Author PubWeight™ 11.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. Eur J Haematol 2010 0.93
2 Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability. Cancer Chemother Pharmacol 2010 0.89
3 Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients. Invest New Drugs 2010 0.86
4 Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Support Care Cancer 2012 0.84
5 Irinotecan, leucovorin and 5-fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer. Oncol Lett 2012 0.84
6 Single-lesion measurement per organ for assessing tumor response in advanced gastric cancer. Oncology 2014 0.81
7 A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients. Cancer Res Treat 2013 0.80
8 Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2013 0.79
9 Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer. Cancer Chemother Pharmacol 2015 0.79
10 Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancer. Lung Cancer 2008 0.78
11 Responsiveness to interferon alpha in chronic hepatitis B by presumed vertical transmission. J Infect 2005 0.77
12 A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer. Lung Cancer 2010 0.76
13 Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer. Cancer Chemother Pharmacol 2013 0.76
14 A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer. Oncol Lett 2011 0.75
15 [A case of gastritis cystica profunda associated with high grade tubular adenoma]. Korean J Gastroenterol 2004 0.75
16 Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2010 0.75